Lucid Diagnostics Inc. Common Stock (LUCD)
Publicly reported company facts and saved market data for Lucid Diagnostics Inc. Common Stock (LUCD), with sources and as-of times. Saved data is not a live quote.
Company profile
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.
Company facts
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $76.4M · as of
- Incorporated in
- United States
- Company website
- www.luciddx.com
- Exchange
- NASDAQ
FennEdge notes
Sessions where LUCD appeared in the Small-Cap Daily, newest first: opening gap, day change and the SEC filing or halt stored by the close. Facts with source links.
- #4 top gapper · gap +32.47% · closed +25.42% 8-K Private placement Lucid Diagnostics Inc. filed an 8-K: Unregistered Sales of Equity, Rights of Security Holders, Charter or Bylaws
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $0.4038
- Reported change
- -6.59%
- Reported volume
- 1,709,215
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float | 156,503,571 | Reported by a single source; not cross-checked. | |
| Shares outstanding (O/S) | 203,243,970 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Short interest
- Reported short interest
- 13,455,236 shares
- Settlement date
- Source
- Market and company data
Exchange-published short interest for the stated settlement date, not a live short position.
Dilution timeline
As of
- · 8-K · Current report filed
- · 424B5 · Prospectus filed
- · 424B5 · Prospectus filed
- · EFFECT · Effectiveness notice filed
- · S-3/A · Shelf registration filed
- · S-3 · Shelf registration filed
- · S-3/A · Shelf registration filed
- · 424B5 · Prospectus filed
- · 424B5 · Prospectus filed
- · 424B3 · Prospectus filed
- · 424B5 · Prospectus filed
- · EFFECT · Effectiveness notice filed
- · S-3 · Shelf registration filed
- · 424B5 · Prospectus filed
- · 424B5 · Prospectus filed
- · 424B5 · Prospectus filed
- · 8-K · Current report filed
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue